comparemela.com

Cl King News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Merit Medical Systems (NASDAQ:MMSI) Now Covered by CL King

Analysts at CL King began coverage on shares of Merit Medical Systems (NASDAQ:MMSI – Get Free Report) in a research report issued on Thursday, Briefing.com reports. The firm set a “buy” rating and a $88.00 price target on the medical instruments supplier’s stock. CL King’s price objective would indicate a potential upside of 22.31% from […]

CL King Begins Coverage on Shockwave Medical (NASDAQ:SWAV)

Stock analysts at CL King initiated coverage on shares of Shockwave Medical (NASDAQ:SWAV – Get Free Report) in a note issued to investors on Wednesday, MarketBeat.com reports. The firm set a “buy” rating and a $368.00 price target on the stock. CL King’s price objective would indicate a potential upside of 13.01% from the company’s […]

Shockwave Medical (NASDAQ:SWAV) Research Coverage Started at CL King

Investment analysts at CL King started coverage on shares of Shockwave Medical (NASDAQ:SWAV – Get Free Report) in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm set a “buy” rating and a $368.00 price target on the stock. CL King’s target price suggests a potential upside of 16.43% from […]

ICU Medical (NASDAQ:ICUI) Research Coverage Started at CL King

CL King began coverage on shares of ICU Medical (NASDAQ:ICUI – Free Report) in a research note published on Thursday morning, Benzinga reports. The firm issued a buy rating and a $110.00 price objective on the medical instruments supplier’s stock. ICUI has been the topic of a number of other reports. StockNews.com assumed coverage on […]

CL King Initiates Coverage on Bloom Energy (NYSE:BE)

Equities research analysts at CL King assumed coverage on shares of Bloom Energy (NYSE:BE – Get Free Report) in a research note issued on Friday, Briefing.com reports. The brokerage set a “buy” rating and a $15.00 price target on the stock. CL King’s price target points to a potential upside of 20.77% from the company’s […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.